Inflammation induces stunting by lowering bone mass via GH/IGF-1 inhibition in very preterm infants

Eduardo Cuestas1, Macarena Hillman2, Silvia Galetto2

  • 1Department of Pediatrics and Neonatology, Hospital Privado Universitario de Córdoba, Instituto Universitario de Ciencias Biomédicas de Córdoba, Córdoba, Argentina. ecuestas@hospitalprivadosa.com.ar.

Pediatric Research
|March 21, 2023
PubMed

Insights

Sustained systemic inflammation in very preterm infants (VPI) leads to stunted growth and lower bone mass. This is linked to inhibited growth hormone/insulin-like growth factor-1 axis, impacting VPI development.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Inflammatory Medicine

Background:

  • Sustained systemic inflammatory response (SIR) is linked to poor postnatal growth in very preterm infants (VPI).
  • The hypothesis is that SIR in VPI leads to linear growth retardation due to reduced bone mass accrual, mediated by Growth Hormone/Insulin-like Growth Factor-1 (GH/IGF-1) axis inhibition at term corrected age (CA).

Purpose of the Study:

  • To investigate the association between sustained SIR and linear growth, bone mass, and GH/IGF-1 axis function in VPI at term CA.
  • To explore the role of inflammatory markers in VPI growth and body composition.

Main Methods:

  • Prospective data collection on inflammatory markers (CRP, PCT), GH, IGF-1, and anthropometric/nutritional data in 23 VPI (<32 weeks GA).
  • Body composition analysis using dual-energy X-ray absorptiometry (DEXA) at term CA.
  • Multiple linear regression models were used for analysis.

Main Results:

  • VPI with sustained SIR (n=11) showed significantly lower IGF-1, length z-score (LZS), bone mineral content (BMC), and lean mass (LM) compared to those without SIR (n=12).
  • Infants with SIR also exhibited higher GH and fat mass (FM).
  • LZS correlated with PCT; BMC with IGF-1; FM and LM with CRP; GH with bronchopulmonary dysplasia and CRP; and IGF-1 with invasive mechanical ventilation, CRP, and PCT.

Conclusions:

  • Sustained SIR in VPI contributes to linear growth failure and reduced bone mass accrual.
  • This is associated with elevated GH and suppressed IGF-1 levels, indicating GH/IGF-1 axis inhibition.
  • SIR may explain non-nutritional factors affecting VPI growth and body composition, highlighting the need to minimize inflammatory stress for improved outcomes.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.6K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K